$PHVS news
The latest PHVS stock news: headlines, filings, AI summaries and sentiment for $PHVS, updated around the clock.
- Pharvaris Reports Third Quarter Financial Results and Clinical Updates
- Pharvaris Reports Positive Late-Stage Trial Results for HAE Drug
- Pharvaris Director Sells $1.3 Million Worth of Shares Amid Strong Stock Performance
- Director Sells $1.3 Million Worth of PHVS Shares Amid Strong One-Year Rally
- Pharvaris Publishes Review on Bradykinin B2 Receptor Antagonism for Angioedema
- Pharvaris CMO Sells Shares Worth $427K
- Pharvaris Director Sells Shares Under Pre-Scheduled Plan
- Pharvaris Director Sells Shares, Impact on Investor Sentiment and Future Outlook